166 related articles for article (PubMed ID: 28567098)
1. Barley Seedling Extracts Inhibit RANKL-Induced Differentiation, Fusion, and Maturation of Osteoclasts in the Early-to-Late Stages of Osteoclastogenesis.
Choi SW; Kim SH; Lee KS; Kang HJ; Lee MJ; Park KI; Lee JH; Park KD; Seo WD
Evid Based Complement Alternat Med; 2017; 2017():6072573. PubMed ID: 28567098
[TBL] [Abstract][Full Text] [Related]
2. Water Extracts of Hull-less Waxy Barley (
Kim KJ; Lee Y; Son SR; Lee H; Son YJ; Lee MK; Lee M
Molecules; 2019 Oct; 24(20):. PubMed ID: 31623242
[TBL] [Abstract][Full Text] [Related]
3. Regulators of osteoclast differentiation and cell-cell fusion.
Miyamoto T
Keio J Med; 2011; 60(4):101-5. PubMed ID: 22200633
[TBL] [Abstract][Full Text] [Related]
4. Fisetin Inhibits Osteoclast Differentiation via Downregulation of p38 and c-Fos-NFATc1 Signaling Pathways.
Choi SW; Son YJ; Yun JM; Kim SH
Evid Based Complement Alternat Med; 2012; 2012():810563. PubMed ID: 23008743
[TBL] [Abstract][Full Text] [Related]
5. Ampelopsis brevipedunculata extract prevents bone loss by inhibiting osteoclastogenesis in vitro and in vivo.
Kim JY; Park SH; Oh HM; Kwak SC; Baek JM; Lee MS; Rho MC; Oh J
Molecules; 2014 Nov; 19(11):18465-78. PubMed ID: 25397737
[TBL] [Abstract][Full Text] [Related]
6. Chaenomelis fructus inhibits osteoclast differentiation by suppressing NFATc1 expression and prevents ovariectomy-induced osteoporosis.
Kim M; Kim HS; Kim JH; Kim EY; Lee B; Lee SY; Jun JY; Kim MB; Sohn Y; Jung HS
BMC Complement Med Ther; 2020 Feb; 20(1):35. PubMed ID: 32024503
[TBL] [Abstract][Full Text] [Related]
7. Cyperus Rotundus L. extract suppresses RANKL-induced osteoclastogenesis through NFATc1/c-fos downregulation and prevent bone loss in OVX-induced osteoporosis rat.
Kum CJ; Kim EY; Kim JH; Lee B; Min JH; Heo J; Kim JH; Yeom M; Sohn Y; Jung HS
J Ethnopharmacol; 2017 Jun; 205():186-194. PubMed ID: 28315458
[TBL] [Abstract][Full Text] [Related]
8. Ethanol extract of Polyscias fruticosa leaves suppresses RANKL-mediated osteoclastogenesis in vitro and LPS-induced bone loss in vivo.
Tran PT; Dang NH; Kim O; Van Cuong P; Dat NT; Hwangbo C; Van Minh C; Lee JH
Phytomedicine; 2019 Jun; 59():152908. PubMed ID: 30981187
[TBL] [Abstract][Full Text] [Related]
9. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
[TBL] [Abstract][Full Text] [Related]
10. Ganomycin I from Ganoderma lucidum attenuates RANKL-mediated osteoclastogenesis by inhibiting MAPKs and NFATc1.
Tran PT; Dat NT; Dang NH; Van Cuong P; Lee S; Hwangbo C; Van Minh C; Lee JH
Phytomedicine; 2019 Mar; 55():1-8. PubMed ID: 30668419
[TBL] [Abstract][Full Text] [Related]
11. Aldehydic components of cinnamon bark extract suppresses RANKL-induced osteoclastogenesis through NFATc1 downregulation.
Tsuji-Naito K
Bioorg Med Chem; 2008 Oct; 16(20):9176-83. PubMed ID: 18823786
[TBL] [Abstract][Full Text] [Related]
12. Protocatechuic Acid Attenuates Osteoclastogenesis by Downregulating JNK/c-Fos/NFATc1 Signaling and Prevents Inflammatory Bone Loss in Mice.
Park SH; Kim JY; Cheon YH; Baek JM; Ahn SJ; Yoon KH; Lee MS; Oh J
Phytother Res; 2016 Apr; 30(4):604-12. PubMed ID: 26792397
[TBL] [Abstract][Full Text] [Related]
13. MiR-7b directly targets DC-STAMP causing suppression of NFATc1 and c-Fos signaling during osteoclast fusion and differentiation.
Dou C; Zhang C; Kang F; Yang X; Jiang H; Bai Y; Xiang J; Xu J; Dong S
Biochim Biophys Acta; 2014 Nov; 1839(11):1084-96. PubMed ID: 25123438
[TBL] [Abstract][Full Text] [Related]
14. Agelasine D suppresses RANKL-induced osteoclastogenesis via down-regulation of c-Fos, NFATc1 and NF-κB.
Kang MR; Jo SA; Yoon YD; Park KH; Oh SJ; Yun J; Lee CW; Nam KH; Kim Y; Han SB; Yu J; Rho J; Kang JS
Mar Drugs; 2014 Nov; 12(11):5643-56. PubMed ID: 25421321
[TBL] [Abstract][Full Text] [Related]
15. Pueraria lobate Inhibits RANKL-Mediated Osteoclastogenesis Via Downregulation of CREB/PGC1β/c-Fos/NFATc1 Signaling.
Park KH; Gu DR; Jin SH; Yoon CS; Ko W; Kim YC; Lee SH
Am J Chin Med; 2017; 45(8):1725-1744. PubMed ID: 29121799
[TBL] [Abstract][Full Text] [Related]
16. Genipin inhibits RANKL-induced osteoclast differentiation through proteasome-mediated degradation of c-Fos protein and suppression of NF-κB activation.
Lee CH; Kwak SC; Kim JY; Oh HM; Rho MC; Yoon KH; Yoo WH; Lee MS; Oh J
J Pharmacol Sci; 2014; 124(3):344-53. PubMed ID: 24646621
[TBL] [Abstract][Full Text] [Related]
17. MiR-30a attenuates osteoclastogenesis via targeting DC-STAMP-c-Fos-NFATc1 signaling.
Yin Y; Tang L; Chen J; Lu X
Am J Transl Res; 2017; 9(12):5743-5753. PubMed ID: 29312525
[TBL] [Abstract][Full Text] [Related]
18. Stauntonia hexaphylla (Lardizabalaceae) leaf methanol extract inhibits osteoclastogenesis and bone resorption activity via proteasome-mediated degradation of c-Fos protein and suppression of NFATc1 expression.
Cheon YH; Baek JM; Park SH; Ahn SJ; Lee MS; Oh J; Kim JY
BMC Complement Altern Med; 2015 Aug; 15():280. PubMed ID: 26271279
[TBL] [Abstract][Full Text] [Related]
19. Sanguiin H-6, a constituent of Rubus parvifolius L., inhibits receptor activator of nuclear factor-κB ligand-induced osteoclastogenesis and bone resorption in vitro and prevents tumor necrosis factor-α-induced osteoclast formation in vivo.
Sakai E; Aoki Y; Yoshimatsu M; Nishishita K; Iwatake M; Fukuma Y; Okamoto K; Tanaka T; Tsukuba T
Phytomedicine; 2016 Jul; 23(8):828-37. PubMed ID: 27288918
[TBL] [Abstract][Full Text] [Related]
20. The Inhibitory Effect of Alisol A 24-Acetate from Alisma canaliculatum on Osteoclastogenesis.
Kim KJ; Leutou AS; Yeon JT; Choi SW; Kim SH; Yee ST; Choi KH; Nam SJ; Son YJ
Int J Endocrinol; 2015; 2015():132436. PubMed ID: 26273291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]